Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00086268
Status:
COMPLETED
Last Update Posted:
2017-09-13
First Post:
2004-06-29
Brief Title:
Non-small Cell Lung Cancer Study US75 Z-PACT
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2017-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ZPACT
Brief Summary:
This study will evaluate the effects of an investigational drug in combination with chemotherapy in patients with stage IIIBIV non-small cell lung cancer This study will measure the effects of this combination on progression of lung cancer cancer response to treatments and development of cancer-related bone lesions
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| US 75 | None | None | None |